Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001326854 | SCV001517905 | likely benign | Hypertrophic cardiomyopathy | 2022-12-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001545359 | SCV001764680 | likely benign | not provided | 2020-10-15 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001806126 | SCV002053614 | uncertain significance | Cardiomyopathy | 2023-06-15 | criteria provided, single submitter | clinical testing | This variant causes a C to T nucleotide substitution at the -4 position of intron 23 of the MYBPC3 gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MYBPC3-related disorders in the literature. This variant has been identified in 2/180278 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002447377 | SCV002734901 | uncertain significance | Cardiovascular phenotype | 2021-07-07 | criteria provided, single submitter | clinical testing | The c.2309-4C>T intronic variant results from a C to T substitution 4 nucleotides upstream from coding exon 24 in the MYBPC3 gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV001326854 | SCV004832810 | uncertain significance | Hypertrophic cardiomyopathy | 2023-10-23 | criteria provided, single submitter | clinical testing | This variant causes a C to T nucleotide substitution at the -4 position of intron 23 of the MYBPC3 gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MYBPC3-related disorders in the literature. This variant has been identified in 2/180278 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |